- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT03108651
Mobile Motivational Messages for Change (3M4Chan) Intervention in TMU
8. april 2019 oppdatert av: Shabbir Syed Abdul, Taipei Medical University
About 100 (50 from TMU Hospital and 50 from Wellcome Clinic) current smokers will be recruited who contact smoke cession clinics in teaching hospitals of Taipei Medical University (TMU) and Wellcome Clinic.
They will be randomly assigned either to Usual Care (UC) or Usual Care plus 3M4Chan Intervention group (IG).
A randomized comparative effectiveness trial will be conducted.
Patient will enroll from September 2017 to May 2018.
In UC group, the physician provides a brief advice to quit during first consultation, a quit plan template, and medication prescription (Varenicline, Bupropion, Champix, Nicotinell TTS20) as decided by the physician.
IG group includes UC plus a mobile App that is programmed to push tailored messages for health concern and readiness to quit, tips for sustaining abstinence, use of interactive self-assessments, helpful cessation information.
This group of smokers will benefit from tailored cessation interventions with integrated body weight management elements that take into consideration the prevailing local and cultural influences on diet and levels of physical activity.
IG will be continued even after stopping of the UC.
Studieoversikt
Status
Fullført
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
92
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Taipei, Taiwan, 11031
- Syed Abdul Shabbir
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
20 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
- Age 20 years or older and approach smoke cessation clinic at TMU hospital
- Have an Android mobile phone
- Able to read Traditional Chinese
- Willing to participate in all study components
- Willing to be followed-up for 6 months
- Smoked at least once every month in the last two years
- Current smoker
Exclusion Criteria:
• Below 20 years on the day of enrolment
- Not willing to participate in the study
- Those who do not have Android mobile phone or unable to read Mandarin
- Not willing to share medical information from EHR
- Subjects who develop adverse effects related to the pharmacological treatment included in the study
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Aktiv komparator: Case
Motivational message will be administrated.
|
Motivational message will be administrated.
|
Ingen inngripen: Control
Motivational message will not be administrated.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Smoking cessation rate at two months
Tidsramme: Up to 2 months
|
Smoking cessation rate will be measured as the ratio of the total number of patients who relapsed with total number of patients in their group.
Patients will be considered to have relapsed if they fail at least one of their urine cotinine and carbon monoxide tests.
|
Up to 2 months
|
Smoking cessation rate at four months
Tidsramme: Up to 4 months
|
Smoking cessation rate will be measured as the ratio of the total number of patients who relapsed with total number of patients in their group.
Patients will be considered to have relapsed if they fail at least one of their urine cotinine and carbon monoxide tests.
|
Up to 4 months
|
Smoking cessation rate at six months
Tidsramme: Up to 6 months
|
Smoking cessation rate will be measured as the ratio of the total number of patients who relapsed with total number of patients in their group.
Patients will be considered to have relapsed if they fail at least one of their urine cotinine and carbon monoxide tests.
|
Up to 6 months
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
User engagement at an individual level
Tidsramme: Up to 6 months
|
Engagement at individual level will be assessed based on the rate of read messages by the patients.
This is calculated as the quotient between the messages the patients have read, and the total number of messages the system has sent to the patients.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
Engagement at aggregated level - Mobile application rolling retention
Tidsramme: Up to 6 months
|
The percentage of users still active N days after installation.
This is a ratio of the number of users whose last day of activity is past day N to the number of users who could have been active on day N.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
Engagement at aggregated level - Mobile application session length distribution
Tidsramme: Up to 6 months
|
The session length is defined as the length of time between the start of the application event and the end of the application event.
The session length determines the engagement as it is relevant to know how much time patients spend in the app per session.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
Engagement at aggregated level - Mobile application session frequency
Tidsramme: Up to 6 months
|
The session frequency is a measure of how often each unique patient used the app within a given time interval.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
Engagement at aggregated level - Mobile application sessions per user
Tidsramme: Up to 6 months
|
A session is one use of the mobile application by a patient.
This begins when the application is launched and ends when the application is terminated.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
Engagement at aggregated level - Mobile application return rate
Tidsramme: Up to 6 months
|
Return rate measures the percentage of patients who return to the app on a specific time after installation.
It is measured by cohort group - that is, based on when patients first opened the app.
It is calculated as the ratio of the number of users active on a given period to the size of the cohort.
This metric will be assessed throughout the observation until its end.
|
Up to 6 months
|
User quitting attempts
Tidsramme: Up to 6 months
|
Number of quitting attempts per patient, including the frequency of the quitting attempts.
|
Up to 6 months
|
User app behavior
Tidsramme: Up to 6 months
|
It will be measured as the time spent per app section.
|
Up to 6 months
|
User satisfaction with messages
Tidsramme: At 6 months after enrolment.
|
Patients' answers to a satisfaction questionnaire that will be handed to them at the end of the study.
|
At 6 months after enrolment.
|
User message ratings
Tidsramme: Up to 6 months
|
User's votes for each message in a 5 star scale.
|
Up to 6 months
|
User lifestyle feedback
Tidsramme: At enrollment and at 6 months after enrollment
|
Comparison of changes in user lifestyle (at baseline and after 6 months) through the combined questionnaire EQ-5D-5L.
|
At enrollment and at 6 months after enrollment
|
User lifestyle feedback
Tidsramme: At enrollment and at 6 months after enrollment
|
Comparison of changes in user lifestyle (at baseline and after 6 months) through the combined questionnaire IPAQ for physical activity.
|
At enrollment and at 6 months after enrollment
|
User lifestyle feedback
Tidsramme: At enrollment and at 6 months after enrollment
|
Comparison of changes in user lifestyle (at baseline and after 6 months) through the combined questionnaires SF-36.
|
At enrollment and at 6 months after enrollment
|
Physical activity
Tidsramme: Up to 6 months
|
The physical activity would be measured as the total time (minutes) of activity per user, retrieved by GoogleFit in the app.
|
Up to 6 months
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Publikasjoner og nyttige lenker
Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. september 2017
Primær fullføring (Faktiske)
2. mars 2019
Studiet fullført (Faktiske)
15. mars 2019
Datoer for studieregistrering
Først innsendt
24. mars 2017
Først innsendt som oppfylte QC-kriteriene
5. april 2017
Først lagt ut (Faktiske)
11. april 2017
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
10. april 2019
Siste oppdatering sendt inn som oppfylte QC-kriteriene
8. april 2019
Sist bekreftet
1. april 2019
Mer informasjon
Begreper knyttet til denne studien
Andre studie-ID-numre
- N201702069
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Case
-
University of PittsburghFullførtHalspulsåren stenoseForente stater
-
Treatment Research InstituteNational Institute on Drug Abuse (NIDA)Fullført
-
Soterix MedicalFullført
-
Sichuan Provincial People's HospitalRekruttering
-
University of OxfordNHS Health Technology Assessment Programme; BUPA FoundationUkjentCarotis stenoseTyskland, Italia, Israel, Storbritannia, Kroatia, Sveits, Kina, Canada, Østerrike, Sverige, Spania, Belgia, Tsjekkia, Frankrike, Forente stater, Brasil, Bulgaria, Egypt, Estland, Hellas, Ungarn, Irland, Japan, Kasakhstan, Nederland, Norge, Polen og mer
-
Xuanwu Hospital, BeijingRekrutteringPlakk for halspulsåren | Stenting av halspulsåren | Carotis endarterektomiKina
-
The First Affiliated Hospital of University of...RekrutteringIskemisk hjerneslag | Carotis stenose | Halspulsåresykdommer | Cerebral revaskulariseringKina
-
Environmental Protection Agency (EPA)FullførtRespirasjonsdepresjonForente stater